Name	Value
Compound	Ly5
Investigated event	Influence on protein activity ex vivo
Experiment type	Western Blot
Concentration	5.00 µM
Cell line	MG63.3
Organism	Mus musculus
Animal model
STAT protein	STAT3
Other

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PloS one Peter Y Yu, Heather L Gardner, Ryan Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K LeBlanc, Hui Xiao, Jiayuh Lin, Denis C Guttridge, Xiaokui Mo, Chad E Bennett, Christopher C Coss, Yonghua Ling, Mitch A Phelps, Peter Houghton, Cheryl A London, 12, 7, None, 2017-07-27, 10.1371/journal.pone.0181885 DOI: 10.1371/journal.pone.0181885 PUBMED: 28750090 PMCID: PMC5531494